Skip to main content
Premium Trial:

Request an Annual Quote

Gregory Hamilton

Epigenomics has appointed Gregory Hamilton as CEO. Hamilton will succeed Thomas Taapken who plans to leave the company. Prior to joining Epigenomics, Hamilton held executive positions in a number of diagnostics companies, including CEO and director of AltheaDx, chief operating officer and CFO of Enigma Diagnostics, vice president of operations and finance at Third Wave Technologies, and vice president of operations at Hologic.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.